APA
O'Day S. J., Eggermont A. M. M., Chiarion-Sileni V., Kefford R., Grob J. J., Mortier L., Robert C., Schachter J., Testori A., Mackiewicz J., Friedlander P., Garbe C., Ugurel S., Collichio F., Guo W., Lufkin J., Bahcall S., Vukovic V. & Hauschild A. (20130506). Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
O'Day Steven J, Eggermont Alexander M M, Chiarion-Sileni Vanna, Kefford Richard, Grob Jean Jacques, Mortier Laurent, Robert Caroline, Schachter Jacob, Testori Alessandro, Mackiewicz Jacek, Friedlander Philip, Garbe Claus, Ugurel Selma, Collichio Frances, Guo Wei, Lufkin Joelle, Bahcall Safi, Vukovic Vojo and Hauschild Axel. 20130506. Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
O'Day S. J., Eggermont A. M. M., Chiarion-Sileni V., Kefford R., Grob J. J., Mortier L., Robert C., Schachter J., Testori A., Mackiewicz J., Friedlander P., Garbe C., Ugurel S., Collichio F., Guo W., Lufkin J., Bahcall S., Vukovic V. and Hauschild A. (20130506). Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
O'Day Steven J, Eggermont Alexander M M, Chiarion-Sileni Vanna, Kefford Richard, Grob Jean Jacques, Mortier Laurent, Robert Caroline, Schachter Jacob, Testori Alessandro, Mackiewicz Jacek, Friedlander Philip, Garbe Claus, Ugurel Selma, Collichio Frances, Guo Wei, Lufkin Joelle, Bahcall Safi, Vukovic Vojo and Hauschild Axel. Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20130506.